Ruth Venning, IRC, NIRI Chair-Elect
Executive Director, Investor Relations
Horizon Therapeutics plc


Ruth Venning is executive director of investor relations for Horizon Therapeutics plc, a $5 billion market cap biopharmaceutical company specializing in medicines for rare diseases.  Working closely with the investment community and Horizon leaders, Venning is integrally involved with day-to-day communication with the investment community, IR strategic planning and messaging, analytics and investor communications.  In addition, she drives Horizon Pharma’s governance outreach and is responsible for Company’s proxy statement, in addition to coordinating the development of investor-relations communications and IR activities.  She is currently spearheading the development of Horizon’s ESG disclosure efforts.

In her current post, Venning draws on her deep experience across several industries in investor relations, corporate communications and crisis management.  Prior to joining Horizon Pharma in May 2017, she served as director of investor relations for Hospira, Inc., a generic injectable pharmaceutical and medical device company acquired by Pfizer in September 2015.  During her 10 years with Hospira, Venning was responsible for day-to-day communication with the investment community, as well as institutional targeting, proxy outreach, retail shareholder relations, and the production of the annual report and other investor materials.  She launched the company’s proxy outreach program in 2010 and spearheaded Hospira’s adoption of the notice-and-access distribution model in 2009, ahead of the adoption curve for practices that now are standard in investor relations.

Before joining Hospira, Venning was director of corporate relations for Telephone and Data Systems, Inc., where she managed corporate communications and investor relations.  Prior to that, she served United Airlines for five years in financial communications and investor relations roles.  Earlier, she directed corporate communications for Calamos Asset Management, a Chicago-area investment management firm.  Venning began her career in international public relations, working primarily for the Japanese government in Japan.

Venning holds an MBA in finance from Lake Forest Graduate School of Management, a master’s degree in corporate communications from Northwestern University, and a bachelor’s degree in Japanese studies from Earlham College.  She is an adjunct instructor in Northwestern University’s Integrated Marketing Communications graduate program.

Venning has served on the NIRI Board of Directors since 2018.  During her tenure, in addition to serving on the Audit Committee, she was an active member of the task forces that generated NIRI’s ESG Disclosure Policy Statement in 2019 and Guidance Policy Statement in 2018.  Also active on a chapter level,  Venning has served on the NIRI-Chicago board of directors since 2004, including as the board’s president in 2007 and chairman in 2008. She currently is the chapter’s treasurer. She also is a member of the National Association of Corporate Directors (NACD) and Women in Bio.

Board Term
2018 - 2021